SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-20-140560
Filing Date
2020-05-12
Accepted
2020-05-12 16:55:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 8006
2 GRAPHIC g844461g0511100750126.jpg GRAPHIC 3171
  Complete submission text file 0001193125-20-140560.txt   13463
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)